MicroRNA miR-302 inhibits the tumorigenicity of endometrial cancer cells by suppression of Cyclin D1 and CDK1.

Gui-Jun Yan,Fei Yu,Bin Wang,Huai-Jun Zhou,Qiu-Yan Ge,Jing Su,Ya-Li Hu,Hai-Xiang Sun,Li-Jun Ding
DOI: https://doi.org/10.1016/j.canlet.2013.11.023
IF: 9.756
2014-01-01
Cancer Letters
Abstract:MicroRNA miR-302 has been found to induce some tumor cell lines to “transdifferentiate” into miRNA-induced pluripotent stem cells (mirPS), thereby inhibiting tumor cell proliferation and reducing tumorigenicity. This study firstly found that miR-302 inhibited the proliferation and migration of endometrial cell line, Ishikawa and HEC-1-B, and arrested cell cycle at the G2/M phase. In addition, miR-302 inhibited tumorigenicity in immunodeficient mice transplanted with Ishikawa cells. Microarray and Western blotting results showed that miR-302 significantly inhibited CDK1 and Cyclin D1 gene expression in Ishikawa cells. MiR-302 directly targeted Cyclin D1, but indirectly regulated CDK1 gene expression.
What problem does this paper attempt to address?